A 35-year-old woman presents to the rheumatology clinic with a 4-month history of symmetrical polyarthritis affecting the small joints of her hands and wrists. She also reports significant fatigue. A novel serum biomarker assay for early systemic lupus erythematosus (SLE) has recently been approved for clinical use. The manufacturer reports that the test has a sensitivity of and a specificity of for diagnosing SLE in patients with undifferentiated inflammatory arthritis. Based on the patient's clinical presentation and demographic profile, the physician estimates her pretest probability of having SLE is .
The patient's blood sample is drawn, and the biomarker assay returns a positive result. Which of the following is the best estimate of the patient's posttest probability of having SLE?
- A
- B
- Answer
- D
- E
Answer
1. Pretest odds =
2. =
3. Posttest odds = Pretest odds
4. Posttest probability =
Therefore, the best estimate of the patient's posttest probability is .